epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

French lavender

lavender

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • alopecia areata [Insufficient Evidence]
  • anxiety [Possibly Effective]
  • aphthous ulcer (canker sores) [Insufficient Evidence]
  • atopic dermatitis (eczema) [Insufficient Evidence]
  • burns [Insufficient Evidence]
  • CABG [Insufficient Evidence]
  • colic [Insufficient Evidence]
  • COVID-19 [Insufficient Evidence]
  • dementia [Insufficient Evidence]
  • depression [Possibly Effective]
  • diabetic neuropathy [Insufficient Evidence]
  • dysmenorrhea [Possibly Effective]
  • fall prevention [Insufficient Evidence]
  • fatigue, cancer-related [Insufficient Evidence]
  • fatigue, cardiac disease-related [Insufficient Evidence]
  • fatigue, chemo-related [Insufficient Evidence]
  • fatigue, multiple sclerosis-related [Insufficient Evidence]
  • fatigue, renal failure-related [Insufficient Evidence]
  • HTN [Insufficient Evidence]
  • insect repellent [Insufficient Evidence]
  • insomnia [Insufficient Evidence]
  • lice [Insufficient Evidence]
  • menopausal symptoms [Insufficient Evidence]
  • migraine, acute [Insufficient Evidence]
  • multiple sclerosis [Insufficient Evidence]
  • nausea/vomiting, postop [Insufficient Evidence]
  • neuropathic pain [Insufficient Evidence]
  • osteoarthritis [Insufficient Evidence]
  • otitis media [Insufficient Evidence]
  • pain, acute [Possibly Effective]
  • pain, cancer-related [Possibly Ineffective]
  • pain, labor-related [Insufficient Evidence]
  • periop anxiety [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • postdural puncture headache [Insufficient Evidence]
  • post-herpetic neuralgia [Insufficient Evidence]
  • postop pain [Insufficient Evidence]
  • postpartum complications [Insufficient Evidence]
  • postpartum depression [Insufficient Evidence]
  • preop anxiety [Insufficient Evidence]
  • pruritus [Insufficient Evidence]
  • psychological well-being [Insufficient Evidence]
  • renal failure [Insufficient Evidence]
  • restless legs syndrome [Insufficient Evidence]
  • stress [Insufficient Evidence]
  • toothache [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information